Overview

Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine Treatment

Status:
Completed

Trial end date:
2016-12-01

Target enrollment:

Participant gender:

Summary

To evaluate efficacy and safety of YH22162 versus telmisartan / amlodipine treatment in patients with hypertension inappropriately controlled on telmisartan/amlodipine treatment

Phase:

Phase 3

Details

Lead Sponsor:

Yuhan Corporation

Treatments:

Amlodipine
Chlorthalidone
Telmisartan
Telmisartan amlodipine combination